Beijing Hotgen Biotech Co., Ltd.
SSE:688068.SS
136.4 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -195.939 | 15.054 | 925.117 | 2,202.377 | 111.296 | 33.748 | 48.188 | 30.072 | 28.799 |
| Depreciation & Amortization
| 90.762 | 70.529 | 120.29 | 68.342 | 29.147 | 21.974 | 16.612 | 10.487 | 7.526 |
| Deferred Income Tax
| 0 | -4.573 | -17.93 | -10.397 | -0.737 | -0.605 | 0.467 | -0.112 | -0.085 |
| Stock Based Compensation
| 0 | 0 | 7.199 | 8.462 | 4.298 | 2.167 | 0 | 0.602 | 0.517 |
| Change In Working Capital
| -18.53 | -72.776 | -247.16 | 259.424 | 16.802 | -46.581 | -15.585 | -23.182 | 1.897 |
| Accounts Receivables
| -77.157 | 92.841 | -22.278 | -81.519 | -19.87 | -25.654 | -10.98 | -12.401 | -4.465 |
| Inventory
| 47.59 | 123.519 | 36.034 | -213.43 | -60.139 | -35.889 | -8.436 | -10.593 | -0.759 |
| Accounts Payables
| 0 | -285.098 | -242.986 | 564.771 | 97.548 | 15.566 | 3.365 | -0.076 | 7.206 |
| Other Working Capital
| 11.037 | -4.037 | -17.93 | -10.397 | -0.737 | -0.605 | -7.148 | -12.589 | 2.656 |
| Other Non Cash Items
| 86.544 | -33.62 | 191.236 | 116.274 | 3.817 | 8.669 | 5.822 | 5.573 | 7.318 |
| Operating Cash Flow
| -37.163 | -25.386 | 978.753 | 2,644.482 | 164.624 | 19.372 | 55.037 | 22.95 | 45.54 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -51.407 | -413.356 | -565.211 | -398.862 | -172.27 | -88.485 | -42.003 | -69.048 | -21.181 |
| Acquisitions Net
| 0 | 0 | 8.82 | 0.133 | 172.315 | 88.485 | -0 | 69.174 | 21.331 |
| Purchases Of Investments
| -1,230.199 | -826.166 | -2,659.933 | -4,909.183 | -1,691 | -412.8 | -100 | -111 | -55 |
| Sales Maturities Of Investments
| 1,399.147 | 1,091.335 | 2,074.592 | 3,565.019 | 1,699.127 | 415.427 | 101.023 | 112.364 | 55.261 |
| Other Investing Activites
| -6.707 | -13.679 | 11.68 | -20 | -172.27 | -88.485 | 0.404 | -69.048 | -21.181 |
| Investing Cash Flow
| 110.835 | -161.867 | -1,130.052 | -1,762.893 | -164.098 | -85.858 | -40.576 | -67.558 | -20.769 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -23.75 | 23.75 | -0.159 | -3.199 | -0.189 |
| Common Stock Issued
| 0 | 0 | 182.325 | 0 | 0 | -15.693 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -16.444 | -150.036 | 0 | 0 | 15.693 | 0 | 0 | 0 |
| Dividends Paid
| -17.344 | 0 | -310.982 | -93.295 | -18.659 | -1.034 | -0.003 | -0.027 | -2.302 |
| Other Financing Activities
| -62.137 | -36.547 | -174.005 | -1.774 | 0.692 | 418.416 | 0.597 | -0.027 | 53.9 |
| Financing Cash Flow
| -79.481 | -36.547 | -484.987 | -95.069 | -42.162 | 425.439 | 0.438 | -3.226 | 51.409 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.154 | -0.465 | 5.198 | -14.833 | 1.403 | 0.127 | 0.272 | -0.056 | 0.009 |
| Net Change In Cash
| -5.963 | -250.828 | -631.088 | 771.688 | -40.234 | 359.08 | 15.17 | -47.889 | 76.188 |
| Cash At End Of Period
| 270.143 | 272.387 | 523.215 | 1,154.302 | 382.615 | 422.849 | 63.769 | 48.599 | 96.488 |